Upgrade to SI Premium - Free Trial

Form 3 Neuronetics, Inc. For: Jul 01 Filed by: Anderson Cory

July 13, 2026 4:15 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Anderson Cory
(Last) (First) (Middle)
C/O NEURONETICS, INC
3222 PHOENIXVILLE PIKE
(Street)
MALVERN PA 19355
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2026 		3. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Gen. Manager, Greenbrook
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 53,205
D
Common Stock 13,336 (1)
D
Common Stock 5,001 (2)
D
Common Stock 3,334 (3)
D
Common Stock 55,003 (4)
D
Common Stock 136,933 (5)
D
Common Stock 150,000 (6)
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Restricted Stock Unit 12/31/2026 (7) 12/31/2027 (7) Common Stock 18,335 (7) 0 (8) D
Performance Restricted Stock Unit 12/31/2026 (9) 12/31/2026 (9) Common Stock 15,000 (9) 0 (8) D
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") award that vests on February 5, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. Represents a RSU award that vests on February 28, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
3. Represents a RSU award that vests on March 28, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
4. Represents a RSU award that vests in two equal annual installments beginning on February 24, 2027, in each case subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
5. Represents a RSU award that vests on June 30, 2027, subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
6. Represents a RSU award that vests in three equal annual installments beginning on February 23, 2027, in each case subject to the Reporting Person's continuous service with the Issuer or its affiliates through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
7. Represents a performance restricted stock unit ("PRSU") award granted on February 24, 2025 and vesting beginning on December 31, 2026, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: (i) 50% of the award will be attained if the Issuer achieves Cash Balance (as defined in the applicable PRSU grant notice) for the fiscal year ended 2026 and (ii) 50% of the award will be attained if the Issuer achieves Cash Balance for the fiscal year ended 2027.
8. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.
9. Represents a PRSU award granted on October 29, 2025 and vesting on December 31, 2026, subject to satisfaction of the applicable performance metrics and continuous service of the Reporting Person through such date. The performance metrics are as follows: the award will be attained if the Issuer achieves Cash Flow Breakeven (as defined in the applicable PRSU grant notice) for the fiscal quarter ended September 30, 2026.
/s/ Patrick Devine, as Attorney-in-Fact 07/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

EX-24

Categories

SEC Filings